Are you 60 years of age or older or do you know someone who is? The Barshop Institute is seeking participants for a clinical trial evaluating whether taking a drug called dapagliflozin (brand name FARXIGA) can inhibit aging-related biomarkers in older, obese adults with pre-diabetes.

Living our institutional values of diversity and inclusion, the Mays Cancer Center, home to UT Health San Antonio MD Anderson, became a founding member of a national coalition lead by Genentech, which aims to increase underrepresented patient populations in clinical trials to improve health equity.   

Barbara Taylor, MD, MS, associate professor of infectious diseases, led the COVID-19 local study site team in partnership with University Health. The Phase 3 global clinical trial enrolled 176 participants here in less than six weeks.

As part of educating the community, plans are underway to fund a multi-site study to test the current standard of care for victims who sustain severe brain trauma in an emergency. Comments for this study are being requested because the normal patient consent process will be suspended due to the unconscious state of the victims. Click here to learn more about the study and complete the community survey.